China Vanke Co. Ltd. buy krebskrebs
Start price
12.07.21
/
50%
€2.62
Target price
12.07.22
€3.40
Performance (%)
-12.21%
End price
13.07.22
€2.30
Summary
This prediction ended on 13.07.22 with a price of €2.30. The price of China Vanke Co. Ltd. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.21%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
China Vanke Co. Ltd. | -16.525% | -16.525% | -63.853% | -83.162% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
Comments by krebskrebs for this prediction
In the thread China Vanke Co. Ltd. diskutieren
Buy mit Kursziel 3,4
In the thread Trading China Vanke Co. Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten